Skip to Content


The complex technical and legal issues in biotechnology require creative and experienced attorneys and patent agents. The practitioners in Haley Guiliano’s biotechnology practice have worked with molecular biology pioneers and are true innovators in the protection of biotechnological inventions. Each team member has a Ph.D. and calls upon that training to both understand the technical nuances of our clients’ needs and for the problem-solving skills research demands.

Haley Guiliano counsels and represents a variety of clients including individual inventors, universities, start-up companies, and mid-size and large biotechnology companies. Our team helps clients maximize the potential of their core technologies, protect their early innovations and develop them into billion-dollar products, and maintain market share in competitive therapeutic spaces. Haley Guiliano works with clients to:

Prepare and prosecute patent applications in the United States Patent and Trademark Office (USPTO).

Coordinate the worldwide prosecution of patent portfolios, including patents covering core technologies, products in clinical development, and blockbuster drugs.

  • Protect their patents or challenge third-party patents in post-grant proceedings at the USPTO and European Patent Office (EPO).
  • Determine strategies for contested proceedings in various foreign patent offices.
  • Evaluate the strengths and weaknesses of their own patent portfolios.
  • Evaluate third party patents for value, validity, and/or freedom operate.
  • Litigate patent infringement proceedings in various tribunals, including the ITC and U.S. Federal District and Appellate Courts.

The practitioners in our biotechnology practice have experience in the prosecution, procurement, evaluation, and litigation of patents and products related to:

  • Antibodies and biologics
  • Immunotherapies
  • Diagnostics and personalized medicine
  • Microbiology and fermentation
  • Neuroscience
  • Virology
  • Enzyme replacement therapy
  • Recombinant DNA technologies
  • Vaccines
  • Transgenic animals
  • Cell-based assays
  • Formulations
  • Drug delivery and dosing


Name Required
Email Required

Communication Policy

While we are happy to have you contact us by electronic mail, telephone, surface mail or facsimile transmission, merely communicating with Haley Guiliano LLP or a Haley Guiliano LLP lawyer or employee will not create a lawyer-client relationship. Such a relationship will not arise unless and until the firm agrees with you in writing to handle a particular matter. Importantly, unless and until this has occurred, you should not convey to us any information you regard as personal or confidential, because any such information will not be treated by us as confidential or subject to any confidentiality requirements.